Although some progress has been made in efforts to combat the opioid epidemic, the latest data from the CDC indicate the crisis is not slowing down. However, it is important for our beneficiaries across the country to know that CMS is exploring all of our options to address this national crisis.
In his first 500 days in office, President Donald J. Trump has achieved results both at home and abroad for the American people, working to ensure government is more accountable to the American people. One of the many promises the Trump Administration has made and kept is improving accountability and transparency in Medicaid.
91 percent of all clinicians eligible for the Merit-based Incentive Payment System (MIPS) participated in the first year of the Quality Payment Program (QPP). The submission rates for Accountable Care Organizations and clinicians in rural practices were at 98 percent and 94 percent, respectively.
CMS in April expanded the Medicare Diabetes Prevention Program (MDPP), a national performance-based payment model offering a new approach to type 2 diabetes prevention in eligible Medicare beneficiaries with an indication of pre-diabetes.
CMS is pleased to announce a new funding opportunity for the development, improvement, updating, and expansion of quality measures for use in the Quality Payment Program. CMS will be partnering with clinicians, patients, and other stakeholders to provide up to $30 million of funding and technical assistance in development of quality measures.
Medicare and other payers are rapidly moving toward a healthcare system that rewards high quality care while spending more wisely. Foundational to the success of these efforts is having quality measures that are meaningful to patients, consumers, and providers alike.